ARCHIVES

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Panel Appointments On President’s Desk; Breast Cancer Treatment Workshop Planned

September 14, 1979

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

November 16, 1979

DCT Board Ok’s Grants Program For AIDS Malignancies, Contracts

October 23, 1992

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

Schmidt Approve NCAB Authorizations

February 18, 1977

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011